drugset / Trial / NCT01476176

A Pharmacokinetic Study of an Experimental Paracetamol Formulation

NCT01476176

Phase 1 Completed 30 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blind

Summary

This PK study is designed to show bioequivalence between the study treatments.

Timeline

Start
2009-07
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule
Subject Caffeine Small molecule

Indications